James J. Ferguson III SEC EDGAR Filings (CIK 0001769041)

SEC EDGAR filings, ownership reports, and insider transactions for James J. Ferguson III.

Business address
C/O Matinas Biopharma Holdings Inc., 1545 Rt. 206 South, Suite 302, Bedminster, NJ, 07921
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
James J. Ferguson III has filed 10 SEC EDGAR filings since 27 Feb 2019

Latest Filings

Recent SEC filings for James J. Ferguson III including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 06 Feb 2025 05 Feb 2025 001-41596
3 Open 3 document View SEC filing for 3 06 Feb 2025 05 Feb 2025 001-41596
4 Open 4 document View SEC filing for 4 15 Dec 2023 15 Dec 2023 001-38022
4 Open 4 document View SEC filing for 4 22 Dec 2022 20 Dec 2022 001-38022
4 Open 4 document View SEC filing for 4 15 Dec 2021 14 Dec 2021 001-38022
4 Open 4 document View SEC filing for 4 04 Jan 2021 01 Jan 2021 001-38022
4 Open 4 document View SEC filing for 4 19 Jun 2020 17 Jun 2020 001-38022
4 Open 4 document View SEC filing for 4 03 Jan 2020 01 Jan 2020 001-38022
4 Open 4 document View SEC filing for 4 27 Feb 2019 25 Feb 2019 001-38022
3 Open 3 document View SEC filing for 3 27 Feb 2019 25 Feb 2019 001-38022

About this filer

James J. Ferguson III files with the SEC under CIK 0001769041. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages